Fresh interest in ICON (NasdaqGS:ICLR) has been triggered by research pointing to strong bookings, a solid order backlog, and a discounted cash flow model suggesting the shares may trade below estimated intrinsic value.
ICON’s recent gains have come after a weaker patch, with a 7 day share price return of 8.87% and a 30 day move of 13.04% indicating improving momentum. However, the year to date share price return is still down 1.80%, and the 3 year total shareholder return has declined 21.27%.
Compare ICON’s rebound story with other potential value opportunities by scanning our hand picked list of 27 high quality undervalued stocks that pair strong fundamentals with discounted prices.
ICON appears to be a solid clinical research operator with bookings and backlog to match. However, the share price has only recently started to recover. Does that recent bounce already reflect its cash flow potential, or not yet?
Most Popular Narrative: 1% Undervalued
ICON’s most followed narrative pegs fair value at $186.76 using a 9.3% discount rate, just above the last close at $185.27. This keeps the focus firmly on whether bookings and margin repair can carry that valuation.
The main factor that has to go right is that ICON converts strong net book-to-bill momentum and new AI and lab investments into healthier direct fee growth and a gradual rebuild of adjusted EBITDA margins, despite mix pressure from pass-throughs and FSP work.
The current valuation suggests the market is treating ICON as fairly valued, with a cautious but constructive view that accounting issues are contained, capital returns via buybacks will resume, and AI and capacity investments can support earnings over time.
See why 13 investors see ICON as 1% undervalued.
Result: Fair Value of $186.76 (UNDERVALUED)
Still, the ICON story can be knocked off course if margin pressure from pass throughs persists or if accounting control concerns keep weighing on the valuation multiple.
Find out about the key risks to this ICON narrative.
Next Steps
Mixed messages on ICON’s outlook can make the picture feel murky, so move quickly to test the numbers, weigh the trade offs, and study the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond ICON?
You do not need to stop with ICON. Put the same disciplined mindset to work across other stocks so you are not relying on a single opportunity.
- Target potential mispricings by scanning a 27 high quality undervalued stocks that combines discounted valuations with stronger fundamentals than the market might be pricing in.
- Strengthen portfolio resilience by reviewing a list of solid balance sheet and fundamentals (25 results) so you focus on businesses with healthier finances backing their prospects.
- Hunt for fresh opportunities by running through a 21 high quality undiscovered gems that highlights under followed companies with quality metrics that may not yet be widely appreciated.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com